oleanolic acid has been researched along with Airflow Obstruction, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, J; Cooper, N; Fox, C; Higham, A; Lea, S; Li, J; Lucas, C; Montero-Fernandez, A; Murray, C; Shah, R; Singh, D | 1 |
| Bedja, D; Biswal, S; Blake, DJ; Champion, HC; El-Haddad, H; Gabrielson, KL; Kensler, TW; Kombairaju, P; Liby, KT; Malhotra, D; Rangasamy, T; Sporn, MB; Sussan, TE; Tuder, RM; Yamamoto, M; Yates, MS | 1 |
2 other study(ies) available for oleanolic acid and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
COPD lung studies of Nrf2 expression and the effects of Nrf2 activators.
Topics: Antioxidants; Humans; Lung; NF-E2-Related Factor 2; Oleanolic Acid; Pulmonary Disease, Chronic Obstructive; Superoxide Dismutase-1 | 2022 |
Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice.
Topics: Animals; Apoptosis; Drug Delivery Systems; Heart Diseases; Hypertension, Pulmonary; Imidazoles; Mice; Mice, Knockout; NF-E2-Related Factor 2; Nitric Oxide; Oleanolic Acid; Oxidative Stress; Pulmonary Alveoli; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Smoke | 2009 |